NOS3 (rs61722009) gene variants testing in prediction of COVID-19 pneumonia severity

[1]  D. Rex,et al.  A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases , 2022, Molecular Biology Reports.

[2]  S. Eroğlu,et al.  The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia , 2022, The American Journal of Emergency Medicine.

[3]  L. Saikrishna,et al.  NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients , 2022, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[4]  N. Tran,et al.  Endothelial Nitric Oxide Synthase (eNOS) and the Cardiovascular System: in Physiology and in Disease States , 2022, American journal of biomedical science & research.

[5]  L. Fishchuk,et al.  Modifying effects of TNF-α, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study , 2021, Drug metabolism and personalized therapy.

[6]  S. Pehlivan,et al.  Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients , 2021, Pathogens and global health.

[7]  R. Webb,et al.  A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19? , 2021, American journal of hypertension.

[8]  The deletion variant of the CCR5 gene (rs333) but not the ACE gene (rs4340) is associated with long-term respiratory support in patients with COVID-19 pneumonia , 2020, Ukrainian Medical Journal.

[9]  H. Handa,et al.  Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms , 2020, Applied Materials Today.

[10]  B. Kennedy,et al.  Does eNOS derived nitric oxide protect the young from severe COVID-19 complications? , 2020, Ageing Research Reviews.

[11]  Jae C. Chang.  Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis , 2020, Thrombosis Journal.

[12]  M. Bauer,et al.  Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review , 2020, Annals of Intensive Care.

[13]  Angelica M. Walker,et al.  A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm , 2020, eLife.

[14]  I. Shuba,et al.  An analysis of association FGB and eNOS3 genes polymorphisms with intracranial hemorrhagic and atherothrombotiс ischemic stroke , 2019 .

[15]  S. Black,et al.  ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) , 2017, Advances in experimental medicine and biology.

[16]  M. Gallegos-Arreola,et al.  eNOS gene Glu298Asp and 4b/a polymorphisms are associated with renal function parameters in Mexican patients with Fabry disease. , 2016, Genetics and molecular research : GMR.

[17]  M. Kim,et al.  Nitric oxide in liver diseases. , 2015, Trends in pharmacological sciences.

[18]  O. Gajic,et al.  SpO2/FiO2 Ratio on Hospital Admission Is an Indicator of Early Acute Respiratory Distress Syndrome Development Among Patients at Risk , 2015, Journal of intensive care medicine.

[19]  W. Zapol,et al.  Nitric oxide synthase 3 contributes to ventilator-induced lung injury. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[20]  S. Salimi,et al.  Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. , 2006, The Indian journal of medical research.

[21]  O. V. Evgenov,et al.  NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice. , 2005, Journal of applied physiology.

[22]  J. Rello,et al.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome , 2004, Intensive Care Medicine.

[23]  D. Dudley,et al.  Haplotype-Specific Effects on Endothelial NO Synthase Promoter Efficiency: Modifiable by Cigarette Smoking , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[24]  S. Neugebauer,et al.  Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. , 2000, Diabetes.

[25]  Y. Kawaguchi,et al.  Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. , 1998, Biochemical and biophysical research communications.

[26]  W. Sessa,et al.  [17] - Transcriptional Control of Endothelial Nitric Oxide Synthase Gene Expression , 1996 .